Articles

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

Hematology Department, CHU Hotel-Dieu, Nantes
Université Pierre & Marie Curie, Paris;INSERM, UMRs 938, Paris;Hôpital Saint-Antoine, AP-HP, Paris
Hematology Department, Hopital Saint-Louis, Paris
Hematology Department, CHU, Bordeaux
Hematology Department, Institut Paoli-Calmette, Marseille
Hematology Department, CHU, Strasbourg, France
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, Hopital Saint-Louis, Paris
Hematology Department, CHU, Bordeaux
Hematology Department, Institut Paoli-Calmette, Marseille
Hematology Department, Institut Paoli-Calmette, Marseille
Hematology Department, CHU, Lyon
Hematology Department, CHU, Strasbourg, France
Hematology Department, CHU, Bordeaux
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, CHU Hotel-Dieu, Nantes;Université Pierre & Marie Curie, Paris;INSERM, UMRs 938, Paris;Hôpital Saint-Antoine, AP-HP, Paris
Vol. 99 No. 9 (2014): September, 2014 https://doi.org/10.3324/haematol.2014.108563